Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-07 Sale | 2023-09-07 5:41 pm | Aditxt Inc. | ADTX | BNP PARIBAS SECURITIES CORP Reduced under 10% owner | 20,800 | $33.23 | $691,140 | 22,342 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-02 5:38 pm | Aditx Therapeutics Inc. | ADTX | Runge Jeffrey W. Director | 10,000 | $2.9344 | $29,344 | 12,500 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-02 4:37 pm | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 490 | $2.93 | $1,436 | 1,016,098 (Indirect) | View |
| 2021-06-01 Purchase | 2021-06-02 12:20 pm | Aditx Therapeutics Inc. | ADTX | Albanna Amro A. CHIEF EXECUTIVE OFFICER | 3,400 | $2.9335 | $9,974 | 751,620 (Direct) | View |
| 2021-06-01 Purchase | 2021-06-02 12:19 pm | Aditx Therapeutics Inc. | ADTX | Albanna Rowena CHIEF OPERATING OFFICER | 3,400 | $2.9335 | $9,974 | 751,620 (Indirect) | View |
| 2021-05-25 Purchase | 2021-05-28 6:49 pm | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 602 | $2.4876 | $1,498 | 2,031,031 (Indirect Direct) | View |
| 2021-05-26 Purchase | 2021-05-27 1:16 pm | Aditx Therapeutics Inc. | ADTX | Farley Thomas J PRINCIPAL ACCOUNTING OFFICER | 2,500 | $2.6799 | $6,700 | 2,500 (Direct) | View |
| 2021-05-25 Purchase | 2021-05-25 8:03 pm | Aditx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER | 4,220 | $2.56 | $10,803 | 114,220 (Direct) | View |
| 2020-07-02 Purchase | 2021-02-12 4:05 pm | Aditx Therapeutics Inc. | ADTX | Kiaie Namvar Director | 1,111 | $0 | $0 | 3,333 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Runge Jeffrey W. Director | 470 | $0 | 470 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Nelson Charles Athle Director | 470 | $0 | 470 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Albanna Rowena Chief Operating Officer | 4,702 | $0 | 4,702 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Albanna Amro A. Chief Executive Officer | 9,404 | $0 | 9,404 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Pankovcin Corinne CCO | 4,702 | $0 | 4,702 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Farley Thomas J Chief Financial Officer | 4,702 | $0 | 4,702 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Brady Brian Michael Director | 470 | $0 | 470 (Direct) | View |
| 2023-11-08 Option Award | 2023-11-13 4:30 pm | N/A 2033-11-08 | Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer | 7,053 | $0 | 7,053 (Direct) | View |
Ownership | 2023-09-05 5:08 pm | N/A N/A | Aditxt Inc. | ADTX | BNP PARIBAS SECURITIES CORP 10% Owner | 0 | $0 | 32,942 (Direct) | View |
Ownership | 2022-02-03 6:43 pm | N/A N/A | Aditxt Inc. | ADTX | Shatzkes Matthew Chief Legal Officer and GC | 0 | $0 | 480,000 (Direct) | View |
| 2021-07-22 Option Award | 2021-11-12 9:51 pm | N/A N/A | Aditxt Inc. | ADTX | Albanna Rowena Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-07-22 Option Award | 2021-11-12 9:50 pm | N/A N/A | Aditxt Inc. | ADTX | Shabahang Shahrokh Chief Innovation Officer | 105,000 | $0 | 105,000 (Direct) | View |
| 2021-07-22 Option Award | 2021-11-12 9:49 pm | N/A N/A | Aditxt Inc. | ADTX | Farley Thomas J Chief Financial Officer | 155,000 | $0 | 155,000 (Direct) | View |
| 2021-07-14 Option Award | 2021-10-01 9:45 pm | N/A N/A | Aditxt Inc. | ADTX | Chung Lauren Director | 14,000 | $0 | 28,000 (Direct) | View |
| 2021-09-29 Option Award | 2021-10-01 7:05 pm | N/A N/A | Aditxt Inc. | ADTX | Kiaie Namvar Director | 11,500 | $0 | 11,500 (Direct) | View |
| 2021-09-29 Option Award | 2021-10-01 7:04 pm | N/A N/A | Aditxt Inc. | ADTX | Brady Brian Michael Director | 11,500 | $0 | 11,500 (Direct) | View |
| 2021-09-29 Option Award | 2021-10-01 7:02 pm | N/A N/A | Aditxt Inc. | ADTX | ANTHONY LAURA E Director | 11,500 | $0 | 11,500 (Direct) | View |
| 2021-09-29 Option Award | 2021-10-01 7:00 pm | N/A N/A | Aditxt Inc. | ADTX | Runge Jeffrey W. Director | 11,500 | $0 | 11,500 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:06 pm | N/A N/A | Aditx Therapeutics Inc. | ADTX | Albanna Amro A. CHIEF EXECUTIVE OFFICER | 75,000 | $0 | 826,620 (Direct) | View |
| 2021-06-04 Option Award | 2021-06-08 4:05 pm | N/A N/A | Aditx Therapeutics Inc. | ADTX | Albanna Rowena CHIEF OPERATING OFFICER | 75,000 | $0 | 826,620 (Indirect) | View |
| 2021-06-04 Option Award | 2021-06-08 4:05 pm | N/A N/A | Aditx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER | 55,000 | $0 | 169,220 (Direct) | View |
Ownership | 2021-03-30 11:59 am | N/A 2030-11-02 | Aditx Therapeutics Inc. | ADTX | Farley Thomas J PRINCIPAL ACCOUNTING OFFICER | 0 | $0 | 60,000 (Direct) | View |
| 2021-03-17 Exercise | 2021-03-22 4:16 pm | N/A N/A | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 18,750 | $4 | 1,015,006 (Indirect) | View |
| 2021-03-17 Exercise | 2021-03-22 4:16 pm | 2018-03-17 2021-03-17 | Aditx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 18,750 | $0 | 1,015,006 (Indirect) | View |
| 2021-02-24 Option Award | 2021-03-01 06:14 am | N/A N/A | Aditx Therapeutics Inc. | ADTX | Albanna Rowena CHIEF OPERATING OFFICER | 225,000 | $0 | 772,220 (Indirect) | View |
| 2021-02-24 Option Award | 2021-03-01 06:13 am | N/A N/A | Aditx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER | 110,000 | $0 | 110,000 (Direct) | View |
| 2021-02-24 Option Award | 2021-03-01 06:11 am | N/A N/A | Aditx Therapeutics Inc. | ADTX | Albanna Amro A. CHIEF EXECUTIVE OFFICER | 225,000 | $0 | 772,220 (Direct) | View |
| 2020-07-22 Ownership | 2021-02-12 4:05 pm | 2020-07-02 2025-07-02 | Aditx Therapeutics Inc. | ADTX | Kiaie Namvar Director | 1,111 | $11.25 | 3,333 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-04 9:31 pm | 2020-11-02 2030-11-02 | ADiTx Therapeutics Inc. | ADTX | Pankovcin Corinne CHIEF FINANCIAL OFFICER | 180,000 | $0 | 180,000 (Direct) | View |
| 2020-11-02 Option Award | 2020-11-04 9:20 pm | N/A 2030-11-02 | ADiTx Therapeutics Inc. | ADTX | Shabahang Shahrokh CHIEF INNOVATION OFFICER | 110,000 | $0 | 110,000 (Direct) | View |